Article info

Original article
Modelling the prevalence of age-related macular degeneration (2010–2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy
  1. Correspondence to Dr Darwin C Minassian, Institute of Ophthalmology, UCL, Bath Street, London EC1V 9EL, UK; d.minassian{at}ucl.ac.uk
View Full Text

Citation

Minassian DC, Reidy A, Lightstone A, et al
Modelling the prevalence of age-related macular degeneration (2010–2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy

Publication history

  • Accepted December 26, 2010
  • First published February 12, 2011.
Online issue publication 
September 21, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.